Hosted on MSN1mon
Proof-of-concept study bioengineers therapeutics for improved cancer treatment
In a proof-of-concept study, the CMRI team has discovered two novel AAV capsids, known as AAV-T1 and AAV-T2, which can produce therapeutic CAR T cells using a five-fold lower dose of the vector.
Artificial Intelligence In 2025: Three Ways To Move From Proof Of Concept To Business Value Generation
Moving from an AI proof of concept to enterprise-wide business value generation is a massive hurdle that takes time and ...
The Bakersfield Californian12d
Mammoth Biosciences Announces New Results on NanoCas – the First Efficient Ultracompact Extrahepatic Gene Editor
Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...